Neuphoria Therapeutics Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Neuphoria Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $14.66M.
- Neuphoria Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $3.16M.
- Neuphoria Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $1.16M, a 19.10% decline year-over-year.
- Neuphoria Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $1.44M.
- Neuphoria Therapeutics Inc. stock issued during period, value, new issues for fiscal 2026 was $17.82M, a 854.13% increase from fiscal 2025.
- Neuphoria Therapeutics Inc. stock issued during period, value, new issues for fiscal 2025 was $1.87M, a 81.53% decline from fiscal 2024.
- Neuphoria Therapeutics Inc. stock issued during period, value, new issues for fiscal 2024 was $10.11M, a 162.07% increase from fiscal 2023.
- Neuphoria Therapeutics Inc. stock issued during period, value, new issues for fiscal 2023 was $3.86M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $17.82M 10-K · filed 2026-09-18 | |
| 2025-12-31 | $14.66M 10-Q · filed 2026-05-15 | |
| 2025-09-30 | $3.16M 10-Q · filed 2026-05-15 | |
| 2025-06-30 | $1.87M 10-K · filed 2026-09-18 | |
| 2025-03-31 | $1.16M 10-Q · filed 2026-05-15 | |
| 2024-06-30 | $10.11M 10-K · filed 2025-09-29 | |
| 2024-03-31 | $1.44M 10-Q · filed 2025-05-20 | |
| 2023-12-31 | -$22.64K 10-Q · filed 2025-05-20 | |
| 2023-09-30 | $612.54K 10-Q · filed 2025-05-20 | |
| 2023-06-30 | $3.86M 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |